Your browser doesn't support javascript.
loading
Gut microbiome is associated with multiple sclerosis activity in children.
Horton, Mary K; McCauley, Kathryn; Fadrosh, Douglas; Fujimura, Kei; Graves, Jennifer; Ness, Jayne; Wheeler, Yolanda; Gorman, Mark P; Benson, Leslie A; Weinstock-Guttman, Bianca; Waldman, Amy; Rodriguez, Moses; Tillema, Jan-Mendelt; Krupp, Lauren; Belman, Anita; Mar, Soe; Rensel, Mary; Chitnis, Tanuja; Casper, Theron Charles; Rose, John; Hart, Janace; Shao, Xiaorong; Tremlett, Helen; Lynch, Susan V; Barcellos, Lisa F; Waubant, Emmanuelle.
Afiliação
  • Horton MK; Division of Epidemiology, University of California, Berkeley, Berkeley, California, USA.
  • McCauley K; Department of Medicine- Gastroenterology, University of California, San Francisco, San Francisco, California, USA.
  • Fadrosh D; Department of Medicine- Gastroenterology, University of California, San Francisco, San Francisco, California, USA.
  • Fujimura K; Department of Medicine- Gastroenterology, University of California, San Francisco, San Francisco, California, USA.
  • Graves J; Department of Neurosciences, University of California, San Diego, La Jolla, California, USA.
  • Ness J; Division of Pediatric Neurology, University of Alabama, Birmingham, Alabama, USA.
  • Wheeler Y; Division of Pediatric Neurology, University of Alabama, Birmingham, Alabama, USA.
  • Gorman MP; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Benson LA; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Weinstock-Guttman B; Department of Neurology, State University of New York, Buffalo, New York, USA.
  • Waldman A; Department of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Rodriguez M; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Tillema JM; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Krupp L; Pediatric Multiple Sclerosis Center, New York University Langone Medical Center, New York, New York, USA.
  • Belman A; Pediatric Multiple Sclerosis Center, New York University Langone Medical Center, New York, New York, USA.
  • Mar S; Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Rensel M; Department of Neurology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Chitnis T; Division of Child Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Casper TC; School of Medicine, University of Utah School, Salt Lake City, Utah, USA.
  • Rose J; School of Medicine, University of Utah School, Salt Lake City, Utah, USA.
  • Hart J; Department of Neurology, University of California, San Francisco, San Francisco, California, USA.
  • Shao X; Division of Epidemiology, University of California, Berkeley, Berkeley, California, USA.
  • Tremlett H; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Lynch SV; Department of Medicine- Gastroenterology, University of California, San Francisco, San Francisco, California, USA.
  • Barcellos LF; Division of Epidemiology, University of California, Berkeley, Berkeley, California, USA.
  • Waubant E; Department of Neurology, University of California, San Francisco, San Francisco, California, USA.
Ann Clin Transl Neurol ; 8(9): 1867-1883, 2021 09.
Article em En | MEDLINE | ID: mdl-34409759
ABSTRACT

OBJECTIVE:

To identify features of the gut microbiome associated with multiple sclerosis activity over time.

METHODS:

We used 16S ribosomal RNA sequencing from stool of 55 recently diagnosed pediatric-onset multiple sclerosis patients. Microbiome features included the abundance of individual microbes and networks identified from weighted genetic correlation network analyses. Prentice-Williams-Peterson Cox proportional hazards models estimated the associations between features and three disease activity

outcomes:

clinical relapses and both new/enlarging T2 lesions and new gadolinium-enhancing lesions on brain MRI. Analyses were adjusted for age, sex, and disease-modifying therapies.

RESULTS:

Participants were followed, on average, 2.1 years. Five microbes were nominally associated with all three disease activity outcomes after multiple testing correction. These included butyrate producers Odoribacter (relapse hazard ratio = 0.46, 95% confidence interval 0.24, 0.88) and Butyricicoccus (relapse hazard ratio = 0.49, 95% confidence interval 0.28, 0.88). Two networks of co-occurring gut microbes were significantly associated with a higher hazard of both MRI outcomes (gadolinium-enhancing lesion hazard ratios (95% confidence intervals) for Modules 32 and 33 were 1.29 (1.08, 1.54) and 1.42 (1.18, 1.71), respectively; T2 lesion hazard ratios (95% confidence intervals) for Modules 32 and 33 were 1.34 (1.15, 1.56) and 1.41 (1.21, 1.64), respectively). Metagenomic predictions of these networks demonstrated enrichment for amino acid biosynthesis pathways.

INTERPRETATION:

Both individual and networks of gut microbes were associated with longitudinal multiple sclerosis activity. Known functions and metagenomic predictions of these microbes suggest the important role of butyrate and amino acid biosynthesis pathways. This provides strong support for future development of personalized microbiome interventions to modify multiple sclerosis disease activity.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article